Actually, we recently have randomly extracted partial data from several clinical trials and analyzed the plasma values of Hsp90α from patients with different types of cancer (including liver, lung, colorectal, breast, stomach, pancreatic, esophagus cancer or lymphoma). This evidence concerns the gene HSP90AA1 and cancer.